ResearcherKU LeuvenActive in the last 2 years
Johannes V. Swinnen
Matched on ORCID iD 0000-0002-7720-5077; OpenAlex author ID A5016435003. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity. Co-author DOI 10.1038/s41467-025-56894-8↗
- Intrinsic temperature increase drives lipid metabolism towards ferroptosis evasion and chemotherapy resistance in pancreatic cancer. Last author DOI 10.1038/s41467-024-52978-z↗
- Drug-induced ciliogenesis in pancreatic cancer cells is facilitated by the secreted ATP-purinergic receptor signaling pathway. Last author DOI 10.18632/oncotarget.23335↗
- Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-016-2540-6↗
- Identification of ciliogenic compounds using pancreatic cancer cells as a screening model Last author DOI 10.1186/2046-2530-4-s1-p57↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Baki Topal · 2 shared papers, 2016–2024 · strength 0.23
- Ana García García · 1 shared paper, 2025 · strength 0.18
- José Luis Rodríguez‐Peralto · 1 shared paper, 2025 · strength 0.18
- Raúl Muñoz Velasco · 1 shared paper, 2025 · strength 0.18
- Victor Javier Sanchez-Arevalo Lobo · 1 shared paper, 2025 · strength 0.18
- Halit Topal · 1 shared paper, 2024 · strength 0.17
- Vincent de Laat · 1 shared paper, 2024 · strength 0.17
- Maria Fedorova · 1 shared paper, 2024 · strength 0.17
- Niamat Ali Khan · 1 shared paper, 2018 · strength 0.12
- N Khan · 1 shared paper, 2015 · strength 0.08
- Anke Van den broeck · 1 shared paper, 2016 · strength 0.06
- Rekin’s Janky · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.